Annexon Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
Terrific. Well, good afternoon, good morning to those on the West Coast. Welcome to the next session of the Raymond James Human Health Innovation Conference. I'm Steve Seedhouse. Really, it is a pleasure for me to welcome the next participating company to this session, Annexon. And joining us in presenting on behalf of Annexon, of course, is CEO, Doug Love. Very much looking forward to the presentation. Thanks so much for being at the conference this year. And with that, Doug, I'll cede the floor and the microphone to you.
Thank you so much, Steve. A real pleasure to be speaking with you this morning and thank all of you for joining us this morning as well. We're excited to share an update on Annexon Biosciences, a lot of good things going on around the company. I will fast-forward through slide 2, our forward-looking statements, but invite you to review those on our website at your leisure.
And turning to slide 3, as many of you know, Annexon is on a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |